Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 153

1.

Quantiferon-TB Gold in tube assay for the screening of tuberculosis before and during treatment with tumor necrosis factor alpha antagonists.

Hatemi G, Melikoglu M, Ozbakir F, Tascilar K, Yazici H.

Arthritis Res Ther. 2012 Jun 18;14(3):R147. doi: 10.1186/ar3882.

2.

Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis.

Inanc N, Aydin SZ, Karakurt S, Atagunduz P, Yavuz S, Direskeneli H.

J Rheumatol. 2009 Dec;36(12):2675-81. doi: 10.3899/jrheum.090268. Epub 2009 Nov 16.

PMID:
19918035
3.

Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea.

Chang B, Park HY, Jeon K, Ahn JK, Cha HS, Koh EM, Kang ES, Koh WJ.

Clin Rheumatol. 2011 Dec;30(12):1535-41. doi: 10.1007/s10067-011-1771-9. Epub 2011 May 10.

PMID:
21556777
4.

Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis.

Hsia EC, Schluger N, Cush JJ, Chaisson RE, Matteson EL, Xu S, Beutler A, Doyle MK, Hsu B, Rahman MU.

Arthritis Rheum. 2012 Jul;64(7):2068-77. doi: 10.1002/art.34382.

5.

Positive conversion of tuberculin skin test and performance of interferon release assay to detect hidden tuberculosis infection during anti-tumor necrosis factor agent trial.

Park JH, Seo GY, Lee JS, Kim TH, Yoo DH.

J Rheumatol. 2009 Oct;36(10):2158-63. doi: 10.3899/jrheum.090150. Epub 2009 Sep 1.

PMID:
19723901
6.

Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy.

Mariette X, Baron G, Tubach F, Lioté F, Combe B, Miceli-Richard C, Flipo RM, Goupille P, Allez M, Salmon D, Emilie D, Carcelain G, Ravaud P.

Ann Rheum Dis. 2012 Nov;71(11):1783-90. doi: 10.1136/annrheumdis-2011-200408. Epub 2012 Jan 17.

PMID:
22258485
7.

Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.

Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S.

Lupus. 2012 Apr;21(5):491-5. doi: 10.1177/0961203311430700. Epub 2011 Dec 2.

PMID:
22140142
8.

[The clinical application of quantiferon TB-2G: its usefulness and limitations].

Sato S, Nagai H.

Kekkaku. 2011 Feb;86(2):101-12. Japanese.

PMID:
21404654
9.

Quantiferon TB Gold and tuberculin skin tests for the detection of latent tuberculosis infection in patients treated with tumour necrosis factor alpha blocking agents.

Klein M, Jarosová K, Forejtová S, Bečvář R, Sedová L, Pavelka K, Simková G, Svobodová R, Hviscová K, Mann H, Půtová I, Vencovský J.

Clin Exp Rheumatol. 2013 Jan-Feb;31(1):111-7. Epub 2012 Oct 24.

PMID:
23101473
10.

The effects of rituximab therapy on released interferon-γ levels in the QuantiFERON assay among RA patients with different status of Mycobacterium tuberculosis infection.

Chen YM, Chen HH, Lai KL, Hung WT, Lan JL, Chen DY.

Rheumatology (Oxford). 2013 Apr;52(4):697-704. doi: 10.1093/rheumatology/kes365. Epub 2012 Dec 22.

11.

Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.

Carmona L, Gómez-Reino JJ, Rodríguez-Valverde V, Montero D, Pascual-Gómez E, Mola EM, Carreño L, Figueroa M; BIOBADASER Group.

Arthritis Rheum. 2005 Jun;52(6):1766-72.

12.

Interferon-gamma release assays in the detection of latent tuberculosis infection in patients with inflammatory arthritis scheduled for anti-tumour necrosis factor treatment.

Mínguez S, Latorre I, Mateo L, Lacoma A, Diaz J, Olivé A, Domínguez J.

Clin Rheumatol. 2012 May;31(5):785-94. doi: 10.1007/s10067-012-1938-z. Epub 2012 Jan 21.

PMID:
22271230
13.

Interferon-γ release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.

Sauzullo I, Mengoni F, Marocco R, Potenza C, Skroza N, Tieghi T, Lichtner M, Vullo V, Mastroianni CM.

Br J Dermatol. 2013 Nov;169(5):1133-40. doi: 10.1111/bjd.12544.

PMID:
23909256
14.

Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.

Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M.

J Rheumatol. 2008 May;35(5):776-81. Epub 2008 Apr 1.

PMID:
18398944
16.

Detecting latent tuberculosis infection during anti-tumor necrosis factor therapy.

Ringrose JS, Sanche SE, Taylor-Gjevre RM.

Clin Exp Rheumatol. 2011 Sep-Oct;29(5):790-4. Epub 2011 Oct 31.

PMID:
21961892
17.

Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.

Chen DY, Shen GH, Chen YM, Chen HH, Hsieh CW, Lan JL.

Ann Rheum Dis. 2012 Feb;71(2):231-7. doi: 10.1136/annrheumdis-2011-200489. Epub 2011 Oct 21.

PMID:
22021896
18.

Mycobacterial infections in patients treated with tumor necrosis factor antagonists in South Korea.

Lee SK, Kim SY, Kim EY, Jung JY, Park MS, Kim YS, Kim SK, Chang J, Kang YA.

Lung. 2013 Oct;191(5):565-71. doi: 10.1007/s00408-013-9481-5. Epub 2013 Jun 1.

PMID:
23728990
19.

Is it safe to use anti-TNF-α agents for tuberculosis in children suffering with chronic rheumatic disease?

Kilic O, Kasapcopur O, Camcioglu Y, Cokugras H, Arisoy N, Akcakaya N.

Rheumatol Int. 2012 Sep;32(9):2675-9. doi: 10.1007/s00296-011-2030-8. Epub 2011 Jul 26.

PMID:
21789614
20.

Safe re-administration of tumor necrosis factor-alpha (TNFα) inhibitors in patients with rheumatoid arthritis or ankylosing spondylitis who developed active tuberculosis on previous anti-TNFα therapy.

Suh YS, Kwok SK, Ju JH, Park KS, Park SH, Yoon CH.

J Korean Med Sci. 2014 Jan;29(1):38-42. doi: 10.3346/jkms.2014.29.1.38. Epub 2013 Dec 26. Erratum in: J Korean Med Sci. 2014 Mar;29(3):460.

Items per page

Supplemental Content

Write to the Help Desk